AGENDA for BIO-EUROPE 2014, November 3-5, 2014, Frankfurt, Germany, Portalhaus Messe Frankfurt

October 13, 2014 by 2012pharmaceutical

AGENDA for BIO-EUROPE 2014, November 3-5, 2014, Frankfurt, Germany, Portalhaus Messe Frankfurt

Reporter: Aviva Lev-Ari, PhD, RN

SOURCE

http://www.partneringone.com/partnering/agenda.php

Monday, Nov 3, 2014 | BIO-Europe 2014

Delegate Schedule set all to available for Monday set all to unavailable for Monday

09:00

Parallel Workshops (09:00–10:30)

The perfect pitch: Do you have what it takes to win over investors? more…

add

Transparency vs. confidentiality of clinical trial data: Challenges and opportunities of the new European Regulation and the new EMA policy more…

add

Translational Medicine: Transforming research achievements into innovative therapeutic and diagnostic products more…

add

What your patents say about you as an innovator: Leveraging your PR into business opportunities more…

add

09:30

10:00

10:30

Welcome, Keynotes, Opening Plenary (10:45-12:30)

Welcome and Opening Remarks (10:45–11:15) more…

Keynote Addresses (11:15-11:45) more…

Opening Plenary Discussion (11:45–12:30) more…

11:00

11:30

12:00

12:30

Lunch

13:00

13:30

unavailable

change

Business Development Track (13:30-14:30)

Mind the GAP? Meeting an emerging demand for access to medicines in late-stage clinical trials, prior to commercial launch more…

add

Spotlight Track (13:30-14:30)

Late stage complications in diabetes

add

Pharma Presentations

13:30 Boehringer Ingelheim Licensing

13:45 Bayer HealthCare Pharmaceuticals

14:00 Janssen Pharmaceutical Companies of Johnson & Johnson

14:15 Merck Serono, a division of Merck KGaA

14:30 MSD

14:45 AstraZeneca

15:00 AbbVie

15:15 Novartis Pharma

15:30 Roche

15:45 Genentech

16:00 Daiichi Sankyo Co., Ltd.

16:15 Pfizer

16:30 GlaxoSmithKline

16:45 Alexion Pharmaceuticals

17:15 Sanofi

17:30 Amgen

17:45 Takeda Pharmaceutical Company Ltd.

18:00 Novo Nordisk

18:15 Bristol-Myers Squibb

14:00

unavailable

change

14:30

unavailable

change

Business Development Track (14:45-15:45)

Access to funding for European companies more…

add

Spotlight Track (14:45-15:45)

Next-generation cancer therapies: What types of partnerships will guide development of targeted and individualized immunotherapies, CSC drugs and other new cancer treatments? more…

add

15:00

unavailable

change

15:30

unavailable

change

16:00

unavailable

change

Business Development Track (16:00-17:00)

Early market access more…

add

Spotlight Track (16:00-17:00)

Corporate views on personalized immune intervention more…

16:30

unavailable

change

17:00

unavailable

change

Business Development Track (17:15-18:15)

The right deal at the right time: How are sell-side dealmakers getting it right, or wrong, in today’s environment? more…

add

Spotlight Track (17:15-18:15)

Advancements in orphan drugs more…

add

17:30

unavailable

change

18:00

unavailable

change

18:30

Tuesday, Nov 4, 2014 | BIO-Europe 2014top

Delegate Schedule set all to available for Tuesday set all to unavailable for Tuesday

08:00

unavailable

change

08:30

unavailable

change

09:00

unavailable

change

Spotlight on SMEs (09:00-10:30)

Innovative funding for SMEs in Europe more…

add

Company Presentations – GI/Metabolic/Diabetes

09:00 Arisgen SA

09:15 BioKIer, Inc.

09:30 GENFIT

09:45 NephroGenex

10:00 RedHill Biopharma

10:15 Antibe Therapeutics Inc.

Company Presentations – Infectious Diseases

09:00 AmpliPhi

09:15 Cempra, Inc.

09:30 MediVector, Inc.

09:45 Synthetic Biologics, Inc.

10:00 Haplogen GmbH

09:30

unavailable

change

10:00

unavailable

change

Company Presentations – additional categories

10:15 Oxyrane more…

10:30 Apricus Biosciences more…

10:45 ObsEva SA more…

11:00 PTC Therapeutics, Inc.more…

11:15 ANERGIS SA more…

11:30 – TBA –

10:30

unavailable

change

Spotlight on SMEs (10:45-11:45)

10:45-11:45 Optimizing your clinical trials for better outcomes and best use of available funding more…

add

Company Pres. – Cell Therapy/Regenerative Medicine

10:30 Cytonet GmbH & Co. KG

10:45 Bone Therapeutics

11:00 K-Stemcell Co Ltd

11:15 NeoStem, Inc.

11:30 Stemmatters SA

11:00

unavailable

change

Company Presentations – Enabling Technologies

11:15 SpeeDx Pty Ltd

11:30 XL-protein GmbH

11:30

unavailable

change

12:00

unavailable

change

Keynote Plenary Discussion (12:00-13:00)

A day in the life of experienced dealmakers: Transformational deals that shaped the industry in 2014 more…

add

12:30

unavailable

change

13:00

unavailable

change

Lunch

13:30

unavailable

change

14:00

unavailable

change

Company Presentations – Autoimmune/Inflammation

14:00 Avexxin AS

14:15 Principia Biopharma

14:30 ActoGeniX NV

14:45 REGiMMUNE Corporation

15:00 Neovacs

Company Presentations – CNS/Neurology

14:00 Alzprotect

14:15 bioExpert

14:30 Cerecor Inc.

14:45 Heptares Therapeutics Ltd

15:00 SanBio, Inc.

15:15 Santhera Pharmaceuticals

15:30 SOM Biotech

15:45 TauRx Pharmaceuticals Ltd.

16:00 UCB Biopharma sprl

Company Presentations – Hessen Trade and Invest

Company Presentations – Midsize Pharma

14:00 BioMarin

14:15 Chugai Pharmaceutical Co., Ltd.

14:30 Debiopharm International S.A.

14:45 DR. KADE Pharmazeutische Fabrik GmbH

15: 00 Grünenthal

15:15 Haisco Pharmaceutical Group Co., Ltd

15:30 Horizon Pharma

15:45 Merck Millipore

14:30

unavailable

change

15:00

unavailable

change

Company Presentations – Cardiovascular

15:15 Juventas Therapeutics

15:30 Resverlogix Corp.

15:45 Sanifit

Company Presentations – Academic Innovators

15:00 Cincinnati Children’s Hospital Medical Center

15:10 imec

15:20 McGill University

15:30 MRC TECHNOLOGY LTD

15:40 Northwestern University – Feinberg School of Medicine

15:50 TTFactor srl

16:00 – TBA –

16:10 Goethe University Frankfurt

16:20 Goethe University Frankfurt

16:30 TI Pharma

15:30

unavailable

change

16:00

unavailable

change

Company Presentations – Service CMO

16:15 Vetter Pharma International

16:30 Boehringer Ingelheim Pharma GmbH & Co. KG

16:45 CEVEC Pharmaceuticals GmbH

17:00 EUFETS GmbH

17:15 Gallus BioPharmaceuticals

17:30 Rentschler Biotechnologie GmbH

17:45 Wacker Biotech GmbH

Company Presentations – Cancer

16:15 Vela

16:30 Apogenix GmbH

16:45 Ability Pharmaceuticals

17:00 BioNTech AG

17:15 ERYTECH

17:30 Isofol Medical AB

17:45 NOXXON Pharma AG

16:30

unavailable

change

Company Presentations – Next Generation

16:40 amcure GmbH

16:50 Lipopharma Therapeutics

17:00 Oxford Pharmascience Group Plc

17:10 ProFactor Pharma Ltd

17:20 Rigontec GmbH

17:30 Synereca Pharmaceuticals

17:40 Zai Laboratory

17:00

unavailable

change

Company Presentations – Vaccines / Autoimmune

17:00 CureVac GmbH more…

17:15 Absynth Biologics Ltd more…

17:30 AFFiRis AG more…

17:45 ci3 more…

17:30

unavailable

change

18:00

unavailable

change

18:30

Wednesday, Nov 5, 2014 | BIO-Europe 2014top

Delegate Schedule set all to available for Wednesday set all to unavailable for Wednesday

08:00

unavailable

change

08:30

unavailable

change

09:00

unavailable

change

Company Presentations – Next Generation

09:00 Jortan Pharmaceuticals

09:10 2bind GmbH more…

09:20 Cormorant Pharmaceuticals more…

09:30 Interceptin more…

09:40 CELLIPSE more…

09:50 Comprehensive Biomarker Center GmbH more…

10:00 Canbex Therapeutics Ltd more…

10:10 Asceneuron SA more…

10:20 HoneyLab more…

10:30 Calypso Biotech SA more…

10:40 NANOMI

10:50 MetaHeps GmbH

Company Presentations – Cancer

09:00 4SC AG

09:15 Berg, LLC

09:30 Oncopeptides AB

09:45 ORYX Translational Medicine

10:00 OXIGENE

10:15 Peregrine Pharmaceuticals, Inc

10:30 PIQUR Therapeutics AG

10:45 PledPharma AB

11:00 Rexahn Pharmaceuticals

11:15 Selvita SA

11:30 BBB Therapeutics

11:45 Oncos Therapeutics Ltd.

12:00 Oncothyreon Inc.

12:15 ONXEO

12:30 Takis

Company Presentations – Antibodies

09:00 arGEN-X

09:15 Genmab

09:30 Innovent Biologics, Inc.

09:45 Midas Pharma

10:00 NB Health Laboratory Co. Ltd.

10:15 Randox Laboratories

09:30

unavailable

change

10:00

unavailable

change

10:30

unavailable

change

Company Presentations – Discovery Platform

10:30 Bioneer A/S

10:45 Chiome Bioscience Inc.

11:00 Kyoto Constella Technologies

11:15 Critical Outcome Technologies Inc.

11:00

unavailable

change

Company Pres. – Biomarkers/Diagnostics/Imaging

11:00 Curasight

11:15 SFC Co., Ltd

11:30 Epigenomics AG

11:30

unavailable

change

Company Presentations – Ophthalmology

11:45 Eyevensys

12:00 Gene Signal SA

12:15 Herantis Pharma

Company Pres. – RNA Therapeutics/Gene Therapy

11:30 Marina Biotech, Inc.

11:45 BioNTech AG

12:00 Genable Technologies

12:15 MaxCyte, Inc.

12:00

unavailable

change

12:30

unavailable

change

Company Presentations – Delivery

12:30 Hovione

12:45 Intec Pharma

13:00

unavailable

change

Lunch

13:30

unavailable

change

14:00

unavailable

change

14:30

unavailable

change

15:00

unavailable

change

15:30

unavailable

change

16:00

unavailable

change

16:30

unavailable

change

Posted in Conference Coverage with Social Media, Technology Transfer: Biotech and Pharmaceutical | Leave a Comment

Comments RSS

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Follow Blog via Email

Recent Posts

Archives

Categories

Meta

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA